Brian Park, PharmD

All articles by Brian Park, PharmD

Clostridioides Difficile

Safety, Efficacy of Oral Microbiome Therapeutic Confirmed in Recurrent CDI Study

By

Brian Park, PharmD

June 13, 2022

The investigational oral microbiome therapeutic SER-109 was found to be safe and effective for the prevention of recurrent CDI.

Study Shows GSK’s RSV Vaccine Candidate Provides Protection for Older Adults

By

Brian Park, PharmD

June 13, 2022

The vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with an adjuvant.

Next post in Respiratory

Poor Sleep Quality Linked to Risk for Exacerbation in COPD